BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10669812)

  • 1. [Pharmaceutical development concerning diseases predominating in tropical regions: the concept of indigent drugs].
    Trouiller P; Rey JL; Bouscharain P
    Ann Pharm Fr; 2000 Jan; 58(1):43-6. PubMed ID: 10669812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orphan drug legislation: lessons for neglected tropical diseases.
    Villa S; Compagni A; Reich MR
    Int J Health Plann Manage; 2009; 24(1):27-42. PubMed ID: 18435430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Orphan drugs].
    Galeffi C
    Ann Ist Super Sanita; 1991; 27(2):341-3. PubMed ID: 1661568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Research and pharmaceutical development on the subject of communicable diseases in the intertropical region].
    Trouiller P
    Sante; 1996; 6(5):299-307. PubMed ID: 8998593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethical issues in funding research and development of drugs for neglected tropical diseases.
    Oprea L; Braunack-Mayer A; Gericke CA
    J Med Ethics; 2009 May; 35(5):310-4. PubMed ID: 19407037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An analysis of the pharmaceuticals market in Vietnam].
    Simonet D
    Sante; 2001; 11(3):155-60. PubMed ID: 11641078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of US military research programs in the development of US Food and Drug Administration--approved antimalarial drugs.
    Kitchen LW; Vaughn DW; Skillman DR
    Clin Infect Dis; 2006 Jul; 43(1):67-71. PubMed ID: 16758420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developing treatments for inborn errors: incentives available to the clinician.
    Haffner ME
    Mol Genet Metab; 2004 Apr; 81 Suppl 1():S63-6. PubMed ID: 15050976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combating tropical infectious diseases: report of the Disease Control Priorities in Developing Countries Project.
    Hotez PJ; Remme JH; Buss P; Alleyne G; Morel C; Breman JG
    Clin Infect Dis; 2004 Mar; 38(6):871-8. PubMed ID: 14999633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Building local research and development capacity for the prevention and cure of neglected diseases: the case of India.
    Kettler HE; Modi R
    Bull World Health Organ; 2001; 79(8):742-7. PubMed ID: 11545331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs for rare diseases: mixed assessment in Europe.
    Prescrire Int; 2007 Feb; 16(87):36-42. PubMed ID: 17323539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Orphan drugs: some legal, ethical and economics aspects].
    Pabst JY
    Rev Epidemiol Sante Publique; 2001 Sep; 49(4):387-96. PubMed ID: 11567205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TDR collaboration with the pharmaceutical industry.
    Gutteridge WE
    Trans R Soc Trop Med Hyg; 2006 Dec; 100 Suppl 1():S21-5. PubMed ID: 16730039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Orphan drugs: problem of public health and economic stakes].
    Brandissou S; Yagoubi N; Hasselot N
    Therapie; 1996; 51(6):647-53. PubMed ID: 9164001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs and diagnostic innovations to improve global health.
    Peeling RW; Nwaka S
    Infect Dis Clin North Am; 2011 Sep; 25(3):693-705, xi. PubMed ID: 21896368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conquering the intolerable burden of malaria: what's new, what's needed: a summary.
    Breman JG; Alilio MS; Mills A
    Am J Trop Med Hyg; 2004 Aug; 71(2 Suppl):1-15. PubMed ID: 15331814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The economics of pediatric formulation development for off-patent drugs.
    Milne CP; Bruss JB
    Clin Ther; 2008 Nov; 30(11):2133-45. PubMed ID: 19108801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic kits in parasitology: which controls?].
    Rossi P
    Parassitologia; 2004 Jun; 46(1-2):145-9. PubMed ID: 15305705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy and safety of chloroquine and alternative antimalarial drugs: a meta-analysis from six African countries.
    Mengesha T; Makonnen E
    East Afr Med J; 1999 Jun; 76(6):314-9. PubMed ID: 10750517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.